Diabetes Mellitus, Type 2 Clinical Trial
— PREVENTOfficial title:
PREVENT - Prediabetes Intervention With Olive Leaf Tea
Verified date | October 2022 |
Source | Instituto Politécnico de Bragança |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this interventional study is investigating the effect of the daily consumption of olive leaves tea on glycemic control of individuals diagnosed with pre-diabetes. The hypothesis of this study is that the integration of olive leaf tea on daily food consumption will favors glycemic control and ameliorate insulin resistance in individuals with pre-diabetes.
Status | Enrolling by invitation |
Enrollment | 140 |
Est. completion date | July 2023 |
Est. primary completion date | March 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: At least one of three glycemic criteria for pre diabetes as defined by 2022 American Diabetes Association (ADA) guidelines: - Fasting plasma glucose level, 100 to 125 mg per deciliter (5.6 to 6.9 mml per liter); - Plasma glucose level 2 hours after a 75-g oral glucose load, 140 to 199 mg per deciliter (7.8 to 11.0 mml per liter); - Glycated hemoglobin level, 5.7 to 6.4% (39 to 47 mml per mole). Exclusion Criteria: - Current use of medication for lowering blood cholesterol, glucose or hypertension; - History of chronic or severe diseases that may affect study outcomes or limit study participation; - Pregnancy and breastfeeding |
Country | Name | City | State |
---|---|---|---|
Portugal | Instituto Politécnico de Bragança | Bragança |
Lead Sponsor | Collaborator |
---|---|
Instituto Politécnico de Bragança | European Social Fund, Unidade Local de Saúde do Nordeste |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HbA1c | Effect of olive leaf tea (OLT) on HbA1c after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Fasting Plasma Glicose | Effect of olive leaf tea (OLT) on FPG after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Insulin | Effect of olive leaf tea (OLT) on Insulin after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Cholesterol Total, c-HDL, c-LDL and triglycerides | Effect of olive leaf tea (OLT) on CT, c-HDL, c-LDL and TG after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Aspartate transaminase (AST) and Alanine transaminase (ALT) | Effect of olive leaf tea (OLT) on AST and ALT after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Alkaline Phosphatase | Effect of olive leaf tea (OLT) on Alkaline Phosphatase after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Bilirubin | Effect of olive leaf tea (OLT) on Bilirubin after 12 weeks of intervention in individuals with prediabetes | 12 weeks | |
Secondary | Creatinine | Effect of olive leaf tea (OLT) on Creatinine after 12 weeks of intervention in individuals with prediabetes | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |